Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule
Product Images NDC 0115-1491

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 0115-1491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E (Dextroamphetamine 1)

FDA Label Image

1 (Dextroamphetamine 2)

FDA Label Image

1 (Dextroamphetamine 3)

FDA Label Image

1 (Dextroamphetamine 4)

FDA Label Image

1 (Dextroamphetamine 5)

FDA Label Image

1 (Dextroamphetamine 6)

FDA Label Image

1 (Dextroamphetamine 7)

This is a medication guide for Extended-Release Capsules containing Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Dextroamphetamine Saccharate. The guide contains important information regarding dosage, usage, possible side effects, and precautions that should be taken while administering this medication. It also contains a QR code which can be scanned to obtain the print version of the guide. The pharmacist is advised to dispense this guide to every patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.